CD147 and matrix-metalloproteinase-2 expression in metastatic and non-metastatic uveal melanomas
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2415
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
CD147 and matrix-metalloproteinase-2 expression in metastatic and non-metastatic uveal melanomas ; volume:16 ; number:1 ; day:3 ; month:6 ; year:2016 ; pages:1-12 ; date:12.2016
BMC ophthalmology ; 16, Heft 1 (3.6.2016), 1-12, 12.2016
- Creator
-
Lüke, Julia
- Contributor
-
Vukoja, Vlatka
Brandenbusch, Tim
Nassar, Khaled
Rohrbach, Jens Martin
Grisanti, Salvatore
Lüke, Matthias
Tura, Aysegül
SpringerLink (Online service)
- DOI
-
10.1186/s12886-016-0222-4
- URN
-
urn:nbn:de:1111-201606047420
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lüke, Julia
- Vukoja, Vlatka
- Brandenbusch, Tim
- Nassar, Khaled
- Rohrbach, Jens Martin
- Grisanti, Salvatore
- Lüke, Matthias
- Tura, Aysegül
- SpringerLink (Online service)
Other Objects (12)
Revealing the structural microenvironment of high metastatic risk uveal melanomas following decellularisation
Expression of matrix metalloproteinase 2 (MMP-2), E-cadherin and Ki-67 in metastatic and non-metastatic canine mammary carcinomas
Small RNAs in metastatic and non-metastatic oral squamous cell carcinoma
Deciphering Stromal Changes between Metastatic and Non-metastatic Canine Mammary Carcinomas
Non-metastatic causes of multiple pulmonary nodules
Novel treatment paradigms for metastatic uveal melanoma
A time course-dependent metastatic gene expression signature predicts outcome in human metastatic melanomas
Mutational analysis in patients with uveal melanomas
Treatment options of metastatic and nonmetastatic VIPoma: a review
Opposite and dynamic regulation of the interferon response in metastatic and non-metastatic breast cancer
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Metastatic recurrence in women diagnosed with non-metastatic breast cancer: a systematic review and meta-analysis
Revealing the structural microenvironment of high metastatic risk uveal melanomas following decellularisation
Expression of matrix metalloproteinase 2 (MMP-2), E-cadherin and Ki-67 in metastatic and non-metastatic canine mammary carcinomas
Small RNAs in metastatic and non-metastatic oral squamous cell carcinoma
Deciphering Stromal Changes between Metastatic and Non-metastatic Canine Mammary Carcinomas
Non-metastatic causes of multiple pulmonary nodules
Novel treatment paradigms for metastatic uveal melanoma
A time course-dependent metastatic gene expression signature predicts outcome in human metastatic melanomas
Mutational analysis in patients with uveal melanomas
Treatment options of metastatic and nonmetastatic VIPoma: a review
Opposite and dynamic regulation of the interferon response in metastatic and non-metastatic breast cancer
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Metastatic recurrence in women diagnosed with non-metastatic breast cancer: a systematic review and meta-analysis
Revealing the structural microenvironment of high metastatic risk uveal melanomas following decellularisation
Expression of matrix metalloproteinase 2 (MMP-2), E-cadherin and Ki-67 in metastatic and non-metastatic canine mammary carcinomas
Small RNAs in metastatic and non-metastatic oral squamous cell carcinoma
Deciphering Stromal Changes between Metastatic and Non-metastatic Canine Mammary Carcinomas
Non-metastatic causes of multiple pulmonary nodules
Novel treatment paradigms for metastatic uveal melanoma
A time course-dependent metastatic gene expression signature predicts outcome in human metastatic melanomas
Mutational analysis in patients with uveal melanomas
Treatment options of metastatic and nonmetastatic VIPoma: a review
Opposite and dynamic regulation of the interferon response in metastatic and non-metastatic breast cancer
Pembrolizumab as first-line treatment for metastatic uveal melanoma